S&P 500   3,369.36 (-0.50%)
DOW   29,188.06 (-0.55%)
QQQ   234.43 (-1.08%)
AAPL   320.39 (-1.00%)
FB   215.26 (-1.03%)
MSFT   184.23 (-1.63%)
GOOGL   1,516.36 (-0.56%)
AMZN   2,150.35 (-0.92%)
CGC   22.38 (+2.80%)
NVDA   309.92 (-1.52%)
BABA   218.47 (-1.65%)
MU   59.27 (-1.20%)
GE   12.55 (-0.48%)
TSLA   889.53 (-3.04%)
AMD   57.16 (-2.95%)
ACB   1.71 (+0.00%)
F   8.05 (+0.63%)
NFLX   384.46 (-0.45%)
BAC   34.84 (+0.35%)
DIS   140.13 (-0.83%)
S&P 500   3,369.36 (-0.50%)
DOW   29,188.06 (-0.55%)
QQQ   234.43 (-1.08%)
AAPL   320.39 (-1.00%)
FB   215.26 (-1.03%)
MSFT   184.23 (-1.63%)
GOOGL   1,516.36 (-0.56%)
AMZN   2,150.35 (-0.92%)
CGC   22.38 (+2.80%)
NVDA   309.92 (-1.52%)
BABA   218.47 (-1.65%)
MU   59.27 (-1.20%)
GE   12.55 (-0.48%)
TSLA   889.53 (-3.04%)
AMD   57.16 (-2.95%)
ACB   1.71 (+0.00%)
F   8.05 (+0.63%)
NFLX   384.46 (-0.45%)
BAC   34.84 (+0.35%)
DIS   140.13 (-0.83%)
S&P 500   3,369.36 (-0.50%)
DOW   29,188.06 (-0.55%)
QQQ   234.43 (-1.08%)
AAPL   320.39 (-1.00%)
FB   215.26 (-1.03%)
MSFT   184.23 (-1.63%)
GOOGL   1,516.36 (-0.56%)
AMZN   2,150.35 (-0.92%)
CGC   22.38 (+2.80%)
NVDA   309.92 (-1.52%)
BABA   218.47 (-1.65%)
MU   59.27 (-1.20%)
GE   12.55 (-0.48%)
TSLA   889.53 (-3.04%)
AMD   57.16 (-2.95%)
ACB   1.71 (+0.00%)
F   8.05 (+0.63%)
NFLX   384.46 (-0.45%)
BAC   34.84 (+0.35%)
DIS   140.13 (-0.83%)
S&P 500   3,369.36 (-0.50%)
DOW   29,188.06 (-0.55%)
QQQ   234.43 (-1.08%)
AAPL   320.39 (-1.00%)
FB   215.26 (-1.03%)
MSFT   184.23 (-1.63%)
GOOGL   1,516.36 (-0.56%)
AMZN   2,150.35 (-0.92%)
CGC   22.38 (+2.80%)
NVDA   309.92 (-1.52%)
BABA   218.47 (-1.65%)
MU   59.27 (-1.20%)
GE   12.55 (-0.48%)
TSLA   889.53 (-3.04%)
AMD   57.16 (-2.95%)
ACB   1.71 (+0.00%)
F   8.05 (+0.63%)
NFLX   384.46 (-0.45%)
BAC   34.84 (+0.35%)
DIS   140.13 (-0.83%)
Log in

NASDAQ:BABY - Natus Medical Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$30.82
-0.13 (-0.42 %)
(As of 02/20/2020 03:04 PM ET)
Today's Range
$30.77
Now: $30.82
$31.24
50-Day Range
$26.75
MA: $29.96
$31.92
52-Week Range
$23.53
Now: $30.82
$37.90
Volume79,447 shs
Average Volume165,325 shs
Market Capitalization$1.05 billion
P/E Ratio21.70
Dividend YieldN/A
Beta0.57
Natus Medical Incorporated provides neurology, newborn care, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction and neurosurgical treatments, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. Read More…

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:BABY
CUSIP63905010
Phone925-223-6700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$530.89 million
Cash Flow$3.28 per share
Book Value$11.80 per share

Profitability

Net Income$-22,930,000.00

Miscellaneous

Employees1,729
Market Cap$1.05 billion
Next Earnings DateN/A
OptionableOptionable

Receive BABY News and Ratings via Email

Sign-up to receive the latest news and ratings for BABY and its competitors with MarketBeat's FREE daily newsletter.


Natus Medical (NASDAQ:BABY) Frequently Asked Questions

What is Natus Medical's stock symbol?

Natus Medical trades on the NASDAQ under the ticker symbol "BABY."

How will Natus Medical's stock buyback program work?

Natus Medical declared that its board has authorized a share repurchase plan on Thursday, February 22nd 2018, which permits the company to repurchase $30,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to reacquire shares of its stock through open market purchases. Shares repurchase plans are usually an indication that the company's board of directors believes its stock is undervalued.

How were Natus Medical's earnings last quarter?

Natus Medical Inc (NASDAQ:BABY) announced its earnings results on Wednesday, October, 24th. The medical equipment provider reported $0.40 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.42 by $0.02. The medical equipment provider had revenue of $130.60 million for the quarter, compared to analyst estimates of $132.92 million. Natus Medical had a negative net margin of 7.38% and a positive return on equity of 10.79%. The firm's revenue for the quarter was up 6.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.40 earnings per share. View Natus Medical's Earnings History.

Has Natus Medical been receiving favorable news coverage?

News coverage about BABY stock has trended extremely negative on Thursday, InfoTrie reports. InfoTrie rates the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Natus Medical earned a news impact score of -4.3 on InfoTrie's scale. They also gave news stories about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Natus Medical.

Who are some of Natus Medical's key competitors?

What other stocks do shareholders of Natus Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Natus Medical investors own include Starbucks (SBUX), Activision Blizzard (ATVI), Gilead Sciences (GILD), Walt Disney (DIS), Intel (INTC), Skyworks Solutions (SWKS), Celgene (CELG), AbbVie (ABBV), Alphabet (GOOG) and NVIDIA (NVDA).

Who are Natus Medical's key executives?

Natus Medical's management team includes the folowing people:
  • Mr. Jonathan A. Kennedy CPA, Pres, CEO & Director (Age 48)
  • Mr. Benjamin Drew Davies, Exec. VP & CFO (Age 53)
  • Mr. Austin F. Noll III, Exec. VP & Chief Commercial Officer (Age 52)
  • Mr. Seán Langan, VP Global Operations
  • Mr. Ivan Pandiyan, VP of Global R&D

Who are Natus Medical's major shareholders?

Natus Medical's stock is owned by many different of retail and institutional investors. Top institutional investors include Fenimore Asset Management Inc. (1.22%), Strs Ohio (0.48%), State of Alaska Department of Revenue (0.08%), Mirador Capital Partners LP (0.07%) and Louisiana State Employees Retirement System (0.03%). Company insiders that own Natus Medical stock include Austin Francis Noll III, Dong Chune Christopher Chung, James B Hawkins, Jonathan Kennedy, Ken Ludlum, Lisa Wipperman Heine, Robert A Gunst and William M Moore. View Institutional Ownership Trends for Natus Medical.

Which major investors are selling Natus Medical stock?

BABY stock was sold by a variety of institutional investors in the last quarter, including Fenimore Asset Management Inc., Louisiana State Employees Retirement System and State of Alaska Department of Revenue. Company insiders that have sold Natus Medical company stock in the last year include Austin Francis Noll III, Dong Chune Christopher Chung, Ken Ludlum and Robert A Gunst. View Insider Buying and Selling for Natus Medical.

Which major investors are buying Natus Medical stock?

BABY stock was bought by a variety of institutional investors in the last quarter, including Strs Ohio and Mirador Capital Partners LP. View Insider Buying and Selling for Natus Medical.

What is Natus Medical's stock price today?

One share of BABY stock can currently be purchased for approximately $30.82.

How big of a company is Natus Medical?

Natus Medical has a market capitalization of $1.05 billion and generates $530.89 million in revenue each year. The medical equipment provider earns $-22,930,000.00 in net income (profit) each year or $1.42 on an earnings per share basis. Natus Medical employs 1,729 workers across the globe.View Additional Information About Natus Medical.

What is Natus Medical's official website?

The official website for Natus Medical is http://www.natus.com/.

How can I contact Natus Medical?

Natus Medical's mailing address is 6701 KOLL CENTER PARKWAY SUITE 120, PLEASANTON CA, 94566. The medical equipment provider can be reached via phone at 925-223-6700 or via email at [email protected]


MarketBeat Community Rating for Natus Medical (NASDAQ BABY)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  290 (Vote Outperform)
Underperform Votes:  314 (Vote Underperform)
Total Votes:  604
MarketBeat's community ratings are surveys of what our community members think about Natus Medical and other stocks. Vote "Outperform" if you believe BABY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BABY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel